Parallel Bio: Funding, Investors & Team (Sep 2026)
Parallel Bio creates tools that aid in the identification and advancement of immunotherapies, aiming to remove obstacles and streamline the process of developing effective drugs. By integrating cutting-edge human immune organoids with advanced computational techniques, Parallel Bio's platform provides novel insights into human health and illness.
Parallel Bio has raised $25.3M across 2 funding rounds on record, the most recent a Series A of $21.0M announced in Jun 2025.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Parallel Bio Company Profile and Key Stats
Latest funding round on record: Jun 2025.
Parallel Bio Funding Rounds
Parallel Bio raised $4.3M in a Seed announced in Dec 2022.
2.5 years later, a Series A of $21.0M was announced in Jun 2025.
Parallel Bio Founders and Leadership Team
Contact details for the Parallel Bio team: 1 of 1 has an email address on file.
Start 14-day free trial →Parallel Bio Funding Compared to Other Biotechnology Startups
Parallel Bio's latest round of $21.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Parallel Bio in Biotechnology and Watertown
Companies Similar to Parallel Bio
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Parallel Bio Funding FAQs
What does Parallel Bio do?
Parallel Bio creates tools that aid in the identification and advancement of immunotherapies, aiming to remove obstacles and streamline the process of developing effective drugs. By integrating cutting-edge human immune organoids with advanced computational techniques, Parallel Bio's platform provides novel insights into human health and illness.
How much funding has Parallel Bio raised?
Parallel Bio has raised $25.3M across 2 rounds on record. The most recent is a Series A of $21.0M announced in Jun 2025.
When did Parallel Bio last raise funding?
Parallel Bio's most recent funding round on record is a Series A of $21.0M, announced in Jun 2025.
Who founded Parallel Bio?
FundedIQ lists Robert Difazio (Founder) at Parallel Bio.
Where is Parallel Bio headquartered?
Parallel Bio is based in Watertown, Massachusetts, United States.
How many employees does Parallel Bio have?
Parallel Bio is in the 11-50 employee band.
How does Parallel Bio's funding compare to other Biotechnology startups?
Parallel Bio's latest round of $21.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Parallel Bio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Parallel Bio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.